Published in Cancer Weekly, September 26th, 2006
Study 1: New therapies are being developed that bring the promise of a cure for leukemia.
"[The study's aim was] to review the current status of resistance to imatinib mesylate (IM) in patients with chronic myelogenous leukemia, and the obstacles and opportunities presented by the development of this resistance. Review of selected studies obtained from a MEDLINE search encompassing the years 1950 to 2004 [was conducted]. Relevant information from the selected studies was abstracted and summarized," researchers in the United States reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.